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Abstract
Refractive errors, in particular myopia, are a leading cause of morbidity and disability world-wide.
Genetic investigation can improve understanding of the molecular mechanisms underlying abnormal
eye development and impaired vision. We conducted a meta-analysis of genome-wide association
studies involving 542,934 European participants and identified 336 novel genetic loci associated with
refractive error. Collectively, all associated genetic variants explain 18.4% of heritability and improve
the accuracy of myopia prediction (AUC=0.75). Our results suggest that refractive error is genetically
heterogeneous, driven by genes participating in the development of every anatomical component of
the eye. In addition, our analyses suggest that genetic factors controlling circadian rhythm and
pigmentation are also involved in the development of myopia and refractive error. These results may
make possible predicting refractive error and the development of personalized myopia prevention
strategies in the future.
Introduction
Refractive errors occur when converging light rays from an image do not clearly focus on the retina.
They are the seventh most prevalent clinical condition1 and the second leading cause of disability in the
world2. The prevalence of refractive error is rapidly increasing, mostly driven by a dramatic rise in the
prevalence of one of its forms, myopia (near-sightedness). Although the causes of such a rise over a
short time are likely due to environmental and cultural changes from the mid-20th century3, refractive
errors are highly heritable4. Several studies5,6 have previously sought to identify genes controlling
molecular mechanisms leading to refractive error and myopia. However, the variance and heritability
that can be attributed to known genetic factors is modest7 and our knowledge of pathogenic
mechanisms remains partial. Here, we conduct a meta-analysis combining data from quantitative
spherical equivalent and myopia status from large and previously unpublished genome-wide association
studies (GWAS) of more than half a million subjects from the UK Biobank, 23andMe and the Genetic
Epidemiology Research on Adult Health and Aging (GERA) cohorts, with subsequent replication and
meta-analysis with data previously reported from the Consortium for Refractive Error and Myopia
(CREAM).
Results
Association Results.
Analyses were restricted to subjects of European ancestry (Extended Data Figure 1) and combined
results from quantitative measures of spherical equivalent and categorical myopia status. Spherical
equivalent quantifies refractive error; a negative spherical equivalent, below a certain threshold defines
myopia. We used results obtained from GWAS of directly measured spherical equivalent in 102,117
population-based UK Biobank participants8, and 34,998 subjects participating in the GERA Study9 and
combined them with results of analyses of self-reported myopia in 106,086 cases and 85,757 controls
from the customer base of 23andMe, Inc. (Mountain View, CA), a personal genomics company10.
Additionally, we included results from an analysis on the refractive status inferred using demographic
and self-reported information on age at first use of prescription glasses among the UK Biobank
participants not contributing to the quantitative GWAS (108,956 likely myopes to 70,941 likely non-
myopes, see Online Methods). All analyses were adjusted for age, sex and main principal components.
To obtain an overall association with refractive error, we meta-analyzed the results from all studies by
using the z-scores from the GWAS of the spherical equivalent and the negative values of z-scores from
the case-control studies (23andMe and UK Biobank), since myopia is negatively correlated with spherical
equivalent. As expected, the large total sample size of the discovery meta-analysis (N=508,855) led to a
nominally large genomic inflation factor (λ=1.94). The LD score regression intercept was (1.17), and the
(intercept-1)/(mean(chi^2)-1) ratio of 0.097 is fully in line with the expectations of polygenicity11.
We found associations for 438 discrete genomic regions (Figure 1, Supplementary Table 1), defined by
markers contiguously associated at conventional level of GWAS significance12,13 of p<5x10-08, separated
by more than 1 Mbp from other GWAS-associated markers, as recommended elsewhere14. Among them,
308 loci, including 14 on chromosome X, were not described in previous GWAS studies of refractive
error7. The observed effect sizes were consistent across all the studies (Supplementary Table 1 and
Supplementary Data 1).  The association with refractive error was statistically strongest for rs12193446
(p=9.87x10-328), within LAMA2, a gene previously associated with refractive error5,6, mutations of which
cause muscular dystrophy15. Consistent with these LAMA2 properties, polymorphisms located within the
genes coding for both major LAMA2 receptors, DAG116 (p=1.67x10-08 for rs111327216) and ITGA717
(p=8.57x10-09 for rs17117860) which are also known causes of muscular dystrophy18,19, were significantly
associated with refractive error in the discovery meta-analysis.
We compared our discovery meta-analysis findings with GWAS results from 34,079 participants in the
CREAM consortium, who were part of a previously reported meta-analysis7. To avoid any potential
overlap with the UK Biobank participants, only non-UK European CREAM participants were used for
replication. Despite the vast power differential, 55 of the SNPs that showed the strongest association in
their respective regions in the discovery meta-analysis were significant after Bonferroni correction in the
replication sample. A further 142 had a false discovery rate (FDR) < 0.05 and 192 were nominally
significant at P < 0.05 (Supplementary Table 2). The effect sizes observed in the discovery and replication
samples were strongly correlated (Pearson’s r=0.91, Extended Data Figure 2). Meta-analysis of all five
cohorts (discovery and replication) expanded the number to 449 associated of regions of variable length
and number of SNPs (Extended Data Figure 3), of which 336 regions were novel (Supplementary Table
3).
Most of the 449 refractive error-associated regions contained at least one gene linked to severe ocular
manifestations in the Online Mendelian Inheritance In Man (OMIM) resource or other genes with
interesting link to eye disease (Supplementary Table 4). Although most loci identified through our meta-
analyses were novel, several of them hosted genes that harbor mutations leading to myopia or other
refractive error phenotypes (Supplementary Data 2). Several genes significantly associated with
refractive error were linked to Mendelian disorders affecting corneal structure, some of which code for
transcription factors involved in corneal development20 (Supplementary Table 5). Mutations in these
genes cause corneal dystrophies (SLC4A11, p=5.81x10-11 for rs41281858, TCF4, p=4.14x10-08,
rs41396445; LCAT, p=1.26x10-10, rs5923; and DCN, p=3.67x10-09, rs1280632), megalocornea (LTBP2,
p=1.91x10-24, rs73296215) and keratoconus (FNDC3B, p=1.89x10-14, rs199771582, previously
described7). Eleven refractive error-associated genes were linked to anomalies of the crystalline lens
(Supplementary Table 6), including genes linked to autosomal dominant cataracts (PAX6 previously
linked to myopia21, p=8.31x10-11, rs1540320; PITX3, p=1.05x10-10, rs7923183; MAF, p=5.50x10-09,
rs16951312; CHMP4B, p=9.95x10 -11 , rs6087538; TDRD7, p=4.79x10-08, rs13301794) and lens ectopia
(FBN1, p=3.30x10-24, rs2017765; ADAMTSL4, p=8.19x10-14, rs12131376). Some of the genes affected
several eye components. For example, LTBP2 variants are also associated with congenital glaucoma22,
and COL4A3 (rs7569375, p=1.14x10-08) causes Alport syndrome, which manifests with abnormal lens
shape (lenticonus) and structural changes in the retina.
Association was also observed within or near 13 genes known to harbor mutations causing
microphthalmia (Supplementary Table 7), including TENM3 (p=2.48x10-11, rs35446926); OTX2
(p=6.15x10-11, rs928109); VSX2, (p=4.60x10-10, rs35797567); MFRP, (p=2.85x10-16, rs10892353) and the
previously identified6 TMEM98, (p=3.49x10-43, rs62067167). Association was also found for VSX1
(p=4.59x10-08 for rs6050351), a gene that is closely regulated by VSX223 and believed to play important
roles in eye development24. Many of the genes nearest associated SNPs have been linked to inherited
retinal disease (Supplementary Table 8), including 32 genes linked to cone-rod dystrophies, night
blindness and retinitis pigmentosa, and age-related macular degeneration (HTRA1/ARMS2).  Among
genes in novel regions associated with refractive error, ABCA4 (p=3.20x10-10 for rs11165052), and
ARMS2/HTRA1 (p=5.72x10-23 for rs2142308) are linked to macular disorders and numerous others to
retinitis pigmentosa, retinal dystrophy and other retinal diseases, such as FBN2, (p=8.63x10-11,
rs6860901) , TRAF3IP1 (p=5.71x10-16, rs7596847), CWC27 (p=1.84x10-18, rs1309551). Significant
association was found near other genes of interest such as DRD1 (p=4.51x10-16, rs13190379), a
dopamine receptor. Together, these results are consistent with previous suggestions of light
transmission and transduction in refractive error7,25.
Wnt signaling has previously been implicated in experimental myopia26. We found significant association
near several Wnt protein-coding genes (WNT7B, a gene previously associated with axial length27,
p=1.42x10-26 for rs73175083; WNT10A, previously associated with central corneal thickness28,
p=1.65x10-17 for rs121908120 and WNT3B, p=8.52x10-16 for rs70600), suggesting that organogenesis
through Wnt signaling is likely to be involved in refractive error. Significant association were found at
genes coding for key canonical (e.g. rs13072632 within the CTNNB1 gene, p=7.30x10-27; AXIN2,
rs9895291, p=1.40x10-08) and non-canonical Wnt pathway members (NFATC3, rs147561310,
p=1.493x10-12) or at genes coding for both (RHOA, rs7623687, p=1.81x10-11 or the previously described7
TCF7L2, rs56299331, p=9.38x10-46; Supplementary Table 9).
Similar to previous published analyses25, we found associations for genes involved in sodium, potassium,
calcium magnesium and other cation transporters (Supplementary Table 10). The involvement of genes
related to glutamatergic synaptic transmission was also notable (Supplementary Table 11). Glutamate is
a first synapse transmitter released by photoreceptors towards bipolar cells and is the main excitatory
neurotransmitter of the retina, and expression of genes participating in glutamate signaling pathways is
significantly altered in myopia models29. These associations support the involvement in refractive error
pathogenesis of neurotransmission and neuronal depolarization and hyperpolarization that was also
suggested before7. Associations with POU6F2 gene intronic variants (rs2696187, p=1.11x10-11) also
suggests involvement of factors related to development of amacrine and ganglion cells30. Other genes at
refractive error-associated loci were annotated to infantile epilepsy, microcephaly, severe learning
difficulty, or other inborn diseases affecting the central nervous system (CNS) in OMIM (Supplementary
Table 12).
Polymorphisms in genes linked to oculocutaneous albinism (OCA) were significantly associated with
refractive error (Supplementary Table 13), although typically association was found for SNPs not
strongly associated with other pigmentation traits31. Strong association with refractive error was found
near the OCA2 gene causing OCA type 2 (p=1.37x10-15, rs79406658), OCA3 (TYRP1, p=1.18x10-11,
rs62538956), OCA5 (SLC39A8, p=4.03x10-17, rs13107325), OCA6 (C10orf11, p=1.73x10-16, rs12256171). In
addition, significant association was found near genes linked to ocular albinism (OA) on chromosome X
(TBL1X and GPR14332, p=2.20x10-18, rs34437079) and Hermansky-Pudlak Syndrome albinism (BLOC1S1,
p=2.4610-22, for rs80340147; note that this gene forms a conjoint read-through transcript the BLOC1S1-
RDH5 with RDH5). Other associated markers were located within genes involved in systemic
pigmentation also previously associated with refractive error7, such as RALY (p=3.14x10-18, rs2284388),
TSPAN10 (p=2.22x-50, rs9747347), as well as melanoma (MCHR2, p=2.37x10-15 for rs4839756).
Functional properties of the associated markers
Among the significantly associated markers, 367 unique markers were frameshift or missense variants
(Supplementary Table 14). Several are non-synonymous, such as the Arg141Leu mutation (rs1048661)
within LOXL1, a gene that causes pseudoexfoliation syndrome and glaucoma33 and Ala69Ser
(rs10490924) in ARMS2, associated with increased susceptibility to age-related macular degeneration34.
Other associated variants with predicted deleterious consequences were located in several genes, such
as RGR (p=6.89x10-68, rs1042454), a gene previously associated with refractive error7,10 and also
retinitis pigmentosa35, and within the FBN1 gene, near clusters of mutations that cause Marfan
Syndrome and anterior segment dysgenesis36.
Because the functional link between other associated variants and development of refractive error
phenotypes is less obvious, we next performed gene-set enrichment analyses to identify properties that
are significantly shared by genes identified by the meta-analysis. An enrichment analysis of Gene
Ontology processes (Supplementary Table 15) found enrichment for genes participating in RNA
Polymerase II transcription regulation (p=1x10-06) and nucleic acid binding transcription factor activity
(p=1.10x10-06), suggesting that many of the genetic associations we identified interfere with gene
expression. “Eye development” (p=6.10x10-06) and “Circadian regulation of gene expression” (p=1.10x10-
04) were also significantly enriched.
A transcription factor binding site (TFBS) enrichment analysis identified significant (FDR < 0.05) over-
representation of sites targeted by GATA4, EP300, RREB1, for which association was observed in the
meta-analyses (Supplementary Table 16). Binding sites of transcription factors involved in eye
morphogenesis and development such as MAF (whose mutations cause autosomal cataract), FOXC1 and
PITX2 (anterior segment dysgenesis) or CRX (cone-rod dystrophy) were also enriched. CRX and PAX4,
binding sites were also significantly enriched; these transcription factors are two of the regulators of
circadian rhythm and melatonin synthesis37 alongside OTX2, for which SNP significant association was
observed in our refractive error meta-analysis (p=6.15x10-11 for rs928109). All of these enriched gene-
sets are observed for the first time in a GWAS analysis, although the presence of some of the
mechanisms that relate them to refractive error and myopia were hypothesized before38.
Many of the variants associated with refractive error in our analyses were located within or near genes
that are expressed in numerous body tissues (Extended Data Figure 4), and in particular from the
nervous system, consistent with our evidence of extraocular, central nervous system involvement in
refractive error. Within the eye, these genes were particularly strongly expressed in eye tissues such as
cornea, ciliary body, trabecular meshwork39 and retina40 (Extended Data Figure 5, Supplementary Table
17). A stratified LD score regression applied to specifically expressed genes (LDSC-SEG)41 revealed the
results of the GWAS are most strongly correlated with genes expressed in the retina and basal ganglia in
the central nervous system but these correlations are not significant after multiple testing correction
(Extended Data Figure 6 and Supplementary Table 18). It is possible that the strength of these
correlations was constrained by the fact that in most cases, available expression levels were measured
in adult samples, while refractive error and myopia are primarily developed in younger ages.
A Summary data-based Mendelian Randomization (SMR) analysis42 integrating GWAS with eQTL data
from peripheral blood43 and brain tissues44 found concomitant association with refractive error and
eQTL transcriptional regulation effects for 159 and 97 genes respectively (Supplementary Tables 19 and
20). A similar analysis integrating GWAS summary data with methylation data from brain tissues found
association with both refractive error and changes in methylation for 134 genes (Supplementary Table
21).
Genetic effects shared between refractive error and other conditions
Examining the GWAS Catalog45, some of the genetic variants reported here were previously associated
with refractive error, and with other traits, in particular intraocular pressure, intelligence and education;
the latter two are known myopia risk factors (Supplementary Table 22). We used LD score regression to
assess the correlation of genetic effects between refractive error and other phenotypes from GWAS
summary statistics (Supplementary Table 23). refractive error genetic risk was significantly correlated
with intelligence, both in childhood46 (rg=-0.27, p=4.76x10-09) and adulthood (fluid intelligence score rg=-
0.25, p=1.56x10-39), educational attainment (defined as the number of years spent in formal education,
rg=-0.24, p=3.36x10-54), self-reported cataract (rg=-0.31, p=4.70x10-10)  and intraocular pressure (IOP, rg=-
0.14, p=1.04x10-12).
Higher educational attainment appears to cause myopia as demonstrated by Mendelian randomization
(MR) studies47. A gene by environment interaction GWAS for spherical equivalent and educational
attainment (using age at completion of formal full-time education as a proxy) was conducted in 66,242
UK Biobank participants. Despite the relatively well-powered sample, only one locus yielded evidence of
statistically significant interaction (rs536015141 within TRPM1, p=2.35x10-09, Supplementary Table 24),
suggesting that the true relationship between refractive error and education is compounded by several
factors and may not be linear in nature, as suggested recently48. TRPM1 is localized in rod ON bipolar cell
dendrites, and rare mutations cause congenital stationary night blindness49, often associated with high
myopia.
To further explore the nature of the relationship between refractive error and IOP, we built MR models
using genetic effects previously reported for IOP50. On average, every 1 mmHg increase in IOP predicts a
0.05-0.09 diopters decrease in spherical equivalent (Supplementary Table 25, Extended Data Figure 7).
We also built a MR model to assess the relationship between intelligence and spherical equivalent, but
statistical evidence in this case points towards genetic pleiotropy rather than causation (Supplementary
Table 26). This suggests that both myopia and intelligence are often influenced by the same factors, but
without direct causal path linking one to the other. We found no significant genetic correlations
between refractive error and the glaucoma endophenotype vertical cup to disc ratio (rg=-0.01, p=0.45),
or hair pigmentation (rg=-0.03, p=0.35). Therefore, refractive error and pigmentation may have different
allelic profiles with limited sharing of genetic risk.
Conditional analysis and risk prediction
We subsequently carried out a conditional analysis51 on the meta-analysis summary results and found a
total of 904 independent SNPs significantly associated with refractive error. 890 of these markers were
available in the EPIC-Norfolk Study, an independent cohort that did not participate in the refractive error
meta-analysis (Extended Data Figure 8). These markers alone explained 12.1% of the overall spherical
equivalent phenotypic variance in a regression model or 18.4% (SE=0.04) of the spherical equivalent
heritability. Newly associated markers found in our meta-analysis, but not in the previous large GWAS7,
explain 4.6% (SE=0.01) of the spherical equivalent phenotypic variance in EPIC-Norfolk Study, which is an
improvement of one third compared to heritability explained by previously associated markers7.
Predictive models, based on the above-mentioned 890 SNPs, along with age and sex, were predictive of
myopia (versus all non-myopia controls) with areas under the receiving operating characteristic curve
(AUC) of 0.67, 0.74 and 0.75 (Figure 2), depending on the severity cutoff for myopia (< -0.75D, < -3.00D
and < -5.00D respectively). The performance of the predictions appears not to improve for myopia
definitions of -3.00D or worse, suggesting that the information extracted from our meta-analysis is more
representative of the genetic risk for common myopia seen in the general population, than for more
severe forms of myopia, which may have a distinctive genetic architecture.
Further exploration of refractive error genetic architecture
Using information from over half a million population-based participants SNPs identified in these
analyses still only explain 18.4% of the spherical equivalent heritability. We next assessed how many
common SNPs are likely to explain the entire heritable component of refractive error, and what sample
sizes are likely to be needed in the future to identify them, using the likelihood-based approach
described elswhere52.  We estimate that approximately 13,808 (SE=969) polymorphic variants are likely
to be behind the full refractive error heritability. Similar to other quantitative phenotypic traits that are
previously published52, our analyses estimate that 10.3% (SE=1.0%) of the phenotypic variance is likely
explained by a batch of approximately 543 (SE=81) common genetic variants of relatively large effect
size and a further 20.8% (SE=0.9%) of the entire phenotypic variance explained by the remainder. With
increased sample sizes, we project that the proportion of variance explained will continue to improve
fast but will start plateauing for sample sizes above one million, after which further increases in sample
size will likely yield ever diminishing additional phenotypic variance (Extended Data Figure 9).
Discussion
Our results provide evidence for at least two major sets of mechanisms in the pathogenesis of refractive
error. The first affect intraocular pressure, eye structure, ocular development and physiology, and the
second are CNS-related, including circadian rhythm control. Contributors to refractive error include all
anatomical factors that alter refractive power relative to eye size, light transmittance,
photoconductance and higher cerebral functions.
The findings implicate almost every single anatomical components of the eye, which along with the
central nervous system participate in the development of refractive error. The healthy cornea
contributes to 70% of the optical refractive power of the eyes53 and genes involved in corneal structure,
topography and function may directly contribute to refractive error through direct changes in the
corneal refraction. Our results show that several genes involved in lens development also contribute to
refractive error in the general population. It is unclear if their contribution is mediated through
alterations in biomechanical properties that affect eyes’ ability to accommodate, changes to the lens
refractive index, or alterations in light transmission properties that impair the ability to focus images on
the retina.
Many retinal genes are implicated in the development of refractive error, reflecting the role of light in
mediating eye growth and the importance of the retina’s role in light transduction and processing7.
Associations with refractive error at genes coding for gated ion channels and glutamate receptors point
to the photoreceptor-bipolar cell interface as a potentially key factor in refractive error. Rare mutations
in several of our associated genes cause night blindness, implicating the rod system in the
pathophysiology of refractive error, but many also affect cone pathways. The TRPM1 gene, important
for rod ON bipolar cell polarity54, is also implicated in the gene-education interaction analysis.
Associations observed for the VSX1 and VSX2, its negative regulator, genes implicate the cone bipolar
cells55.
The association with genes involved in pigmentation, including most of the OCA-causing genes, raises
questions about the relationship between melanin, pigmentation and eye growth and development.
These associations are unlikely to be influenced by any cryptic population structure in our samples,
which our analyses were designed to control. None of the major pigmentation-associated SNPs31 was
directly associated with refractive error and there was no significant correlation of genetic effects
between refractive error and pigmentation.
The mechanisms linking pigmentation with refractive error are unclear. Foveal hypoplasia56 and optic
disc57 dysplasias are common in all forms of albinism58. Although melanin synthesis is disrupted in
albinism, both melanin and dopamine are synthesized through shared metabolic pathways. Disc and
chiasmal lesions in albinism are often attributed to dopamine59, but we found limited evidence
supporting an association with refractive error for genetic variants involved in dopamine signaling. The
scarcity of association with refractive error for genes involved in dopamine-only pathways contrasts
with the abundance of association for genes involved in pigmentation and melanin synthesis. This may
suggest that melanin metabolism is connected to refractive error through other mechanisms that are
independent from the metabolic pathways it shares with dopamine production. Melanin reaches the
highest concentrations in the retinal pigment epithelium at the outmost layer of the retina, and
anteriorly, in the iris and variations in pigmentation may affect the intensity of the light reaching the
retina. Light exposure is a major protective factor for development of myopia60,61 It is possible that
pigmentation plays a role in light signal transmission and transduction.
Animal model experiments suggest that in addition to local ocular mechanisms, emmetropization (the
process by which the eye develops to minimize refractive error) is strongly influenced by the CNS62. The
strong correlation of genetic risks between refractive error and intelligence and association found for
genes linked to severe learning disability support an involvement of the CNS in emmetropization and
refractive error pathogenesis.
Results from gene-set enrichment analysis demonstrate an interesting evolution with increasing sample
sizes. While smaller previous studies were sufficiently powered to discover enrichment of low, cell-level
properties, such as cation channel activity and participation in the synaptic space structures25,
significantly more powered recent studies have found additional evidence for enrichment and
involvement of more integrated physiological functions, such as light signal processing in retinal cells
and others7. Beyond the identification of a much larger number of genes and explaining significantly
higher proportions of heritability, our results, based in a considerably more statistically powered sample,
uphold the previous findings and support the involvement of the same molecular and physiological
mechanisms that were previously described.
In line with expectations from a higher power of association to discover genes and gene sets individually
responsible for even smaller proportions of the refractive error variance63, we find evidence for even
higher regulatory mechanisms, that act more holistically over the eye development or integrate eye
growth and homeostasis with other processes of extraocular nature. For example, we found evidence
that binding sites of transcription factors involved in the control of circadian rhythm are significantly
enriched among genes associated with refractive error. Circadian rhythm is important in
emmetropization and its disruption leads to myopia in animal knock-out models38, potentially through
dopamine-mediated mechanisms, or changes in IOP and diurnal variations.
Most of the loci identified through our meta-analysis are not subject to particularly strong and
systematic evolutionary pressures (Extended Data Figure 10). The variability in minor allele frequencies
observed across loci associated with refractive error may therefore be the result of genetic drift.
However, given the variety of the different visual components whose disruptions can result in refractive
error, this variability may also be the result of overall balancing forces which encourage high allelic
diversity of genes involved in refractive error, providing additional buffering capacity to absorb
environmental pressures48 or genetic disruptions on any of the individual components of the visual
system.
Our results cast light on potential mechanisms that contribute to refractive error in the general
population and have identified the genetic factors that explain a considerable proportion of the
heritability and phenotypic variability of refractive error. This allows us to improve significantly our
ability to make predictions of myopia risk and generate novel hypotheses on how multiple aspects of
visual processing affect emmetropization, which may pave the way to personalized risk management
and treatment of refractive error in the population in the future.
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Figure Legends
Figure 1. All GWAS-associated regions from the main meta-analysis. Each band is a true scale of genomic
regions associated with refractive error listed in Supplementary Table 1 (+250kbp on each side to make
smaller regions more visible). The different color codes represent the significance (p-value) for the
genetic variant within that region that displays the strongest evidence for association.
Figure 2. Receiver Operating Characteristic (ROC) curves for myopia predictions, using information from
890 SNP markers identified in the meta-analysis. The three different colors represent three different
curves for each of the different definition of myopia: green – all myopia (< -0.75D), magenta – moderate
myopia (< -3.00 D) and brown - severe myopia (defined as < -5.00 D).
Online Methods
Study Participants
The UK Biobank
The UK Biobank is a multisite cohort study of UK residents aged 40 to 69 years who were registered with
the National Health Service (NHS) and living up to 25 miles from a study center.  Detailed study
protocols are available online (http://www.ukbiobank.ac.uk/resources/ and
http://biobank.ctsu.ox.ac.uk/crystal/docs.cgi).   It was conducted with the approval of the North-West
Research Ethics Committee (ref 06/MRE08/65), in accordance with the principles of the Declaration of
Helsinki, and all participants gave written informed consent.
Two separate groups of UK Biobank participants were included in these analyses. The first included
participants whose refractive error was directly measured (non-cycloplegic autorefraction using the
Tomey RC 5000 Auto Refkeratometer, Tomey Corp., Nagoya, Japan). Direct measurements of refractive
errors were available for 22.7% of the UK Biobank sample. To ensure reliable and accurate refractive
error data, previously published QC criteria were applied64. The spherical equivalent was calculated as
spherical refractive error (UK Biobank codes 5084 and 5085) plus half the cylindrical error (UK Biobank
5086 and 5087) for each eye.
The second UK Biobank group included participants without direct measurement of refractive error.
These participants refractive error status was inferred using questionnaire and other indirect data.
Available demographic and clinical information were used to obtain an estimate about the individual’s
likely myopia status. A Support Vector Machine (SVM) model, with age, sex, age of first spectacle wear
and year of birth as prediction parameters was used to infer participants’ myopia status. Initial training
took place in 80% randomly selected UK Biobank participants of European descent for whom direct
spherical equivalent and refractive error status were available. Then the performance was assessed in
the remaining 20% of UK Biobank participants of European descent for whom direct spherical equivalent
and refractive error status were available. Finally, the SVM predictions in the remaining individuals with
no direct spherical error measurements available using the model developed for the training data.
All UK Biobank genotypes were obtained as described elsewhere65. The UK Biobank team then
performed imputation from a combined Haplotype Reference Consortium (HRC) and UK10K reference
panel. Phasing on the autosomes was carried out using a modified version of the SHAPEIT266 program
modified to allow for very large sample sizes. Only HRC-imputed variants were used for the purpose our
analyses of the UK Biobank participants. The variant-level quality control exclusion metrics applied to
imputed data for GWAS included the following: call rate < 95%, Hardy–Weinberg equilibrium P <1 × 10−6,
posterior call probability < 0.9, imputation quality < 0.4, and MAF < 0.005. The Y chromosome and
mitochondrial genetic data were excluded from this analysis. In total, 10,263,360 imputed DNA
sequence variants were included in our analysis. Non-European ancestry and participants with
relatedness corresponding to third-degree relatives or closer, samples with excess of missing genotype
calls or heterozygosity were excluded. In total, genotypes were available for 102,117 participants of
European ancestry with spherical equivalent data.
Association models in the first UK Biobank subset used the average of spherical equivalent as the
outcome and allele dosages at each genetic locus as predictors. Mixed linear regressions, adjusting for
age, sex and the first 10 principal components, implemented in the Bolt-LMM software67 were used.
For the second UK Biobank subset, for which no direct spherical equivalent measurement was available,
the mixed linear model was built with the predicted myopia status as outcome and using the same
covariates as for the previously described linear regression analysis on spherical equivalent. Odds Ratios
were obtained from the beta regression coefficient using the equation:ln (OR) = βμ(1 − μ)
where μ is the fraction of the cases in the sample (μ=0.606). Genotypes with MAF <0.01 and MAC< 400
were removed from analyses in this group.
23andMe
Participating subjects were all volunteers from the 23andMe (Mountain View, CA, USA) personal
genomics company customer base. All participants provided informed consent and answered surveys
online according to the approved 23andMe human subjects protocol, which was reviewed and approved
by Ethical & Independent Review Services, a private institutional review board
(http://www.eandireview.com). The participants were identified as myopia cases if they self-reported a
diagnosis of myopia or suffering from symptoms of myopia (see Supplementary Notes for more detail).
DNA extraction and genotyping were performed on saliva samples by CLIA-certified and CAP-accredited
clinical laboratories of Laboratory Corporation of America. Samples were genotyped on one of four
genotyping platforms and batches (Illumina HumanHap550, BeadChip, SNPs, Illumina OmniExpress, plus
a variable number of custom SNP assays). Only samples with more than 98.5% genotyping success rate
were included. Ethnic categorization was conducted using a support vector machine (SVM) which
classified individual haplotypes into one of the 31 reference populations derived from public datasets
(the Human Genome Diversity Project, HapMap, and 1000 Genomes), as well as 23andMe customers
who have reported having four grandparents from the same country. Genotypes were imputed against
the September 2013 release of 1000 Genomes Phase1 reference haplotypes using a Beagle haplotype
graph-based phasing algorithm for the autosomal and Minimac268 for X Chromosome loci.
Association test results were computed by linear regression assuming additive allelic effects using
imputed allele dosages. Covariates for age, gender, the first ten principal components to account for
residual population structure were also included into the model.
The Genetic Epidemiology Research in Adult Health and Aging (GERA) cohort
GERA is part of the Kaiser Permanente Research Program on Genes, Environment, and Health (RPGEH)
and has been described in detail elsewhere69. It comprises adult men and women consenting members
of Kaiser Permanente Northern California (KPNC), an integrated health care delivery system, with
ongoing longitudinal records from vision examinations. For this analysis, 34,998 adults (25 years and
older), who self-reported as non-Hispanic white, and who had at least one assessment of spherical
equivalent obtained between 2008 and 2014 were included. All study procedures were approved by the
Institutional Review Board of the Kaiser Foundation Research Institute. Participants underwent vision
examinations, and most subjects had multiple measures for both eyes. Spherical equivalent was
assessed as the sphere + cylinder/2. The spherical equivalent was selected from the first documented
assessment, and the mean of both eyes was used. Individuals with histories of cataract surgery (in either
eye), refractive surgery, keratitis, or corneal diseases were excluded from further analyses.
DNA samples from GERA individuals were extracted from Oragene kits (DNA Genotek Inc., Ottawa, ON,
Canada) at KPNC and genotyped at the Genomics Core Facility of the University of California, San
Francisco (UCSF). DNA samples were genotyped using the Affymetrix Axiom arrays (Affymetrix, Santa
Clara, CA, USA). SNPs with initial genotyping call rate ≥97%, allele frequency difference ≤0.15 between
males and females for autosomal markers, and genotype concordance rate >0.75 across duplicate
samples were included. In addition, SNPs with genotype call rates <90% were removed, as well as SNPs
with a minor allele frequency (MAF) < 1%.
Imputation pre-phasing of genotypes was done using Shape-IT v2.r7271966, variants were imputed from
the cosmopolitan 1000 Genomes Project reference panel (phase I integrated release;
http://1000genomes.org) using IMPUTE2 v2.3.070. Variants with an imputation IMPUTE r2 < 0.3 were
excluded, and analyses were restricted to SNPs that had a minor allele count (MAC) ≥ 20.
For each SNP locus, linear regressions of each individual’s spherical equivalent were performed with the
following covariates: age at first documented spherical equivalent assessment, sex, and genetic principal
components using PLINK v1.9 (www.cog-genomics.org/plink/1.9/). Data from each SNP were modeled
using additive dosages to account for the uncertainty of imputation. The top 10 ancestry PCs were
included as covariates, as well as the percentage of Ashkenazi ancestry to adjust for genetic ancestry, as
described previously69.
The Consortium for Refractive Error And Myopia (CREAM)
All participants selected for this study were of European descent, 25 years of age or older. refractive
error was represented by measurements of refraction and spherical equivalent (Spherical
equivalent = spherical refractive error +1/2 cylinder refractive error) was the outcome variable for
CREAM. Participants with conditions that could alter refraction, such as cataract surgery, laser
refractive procedures, retinal detachment surgery, keratoconus, or ocular or systemic syndromes
were excluded from the analyses. Recruitment and ascertainment strategies varied by study and
were previously published elsewhere71.
The genotyping process has been described elsewhere71.  Samples were genotyped on different
platforms, and study-specific QC measures of the genotyped variants were implemented before
association analysis. Genotypes were imputed with the appropriate ancestry-matched reference panel
for all cohorts from the 1000 Genomes Project (Phase I version 3, March 2012 release). Quality control
criteria used for SNP and sample inclusions These metrics were similar to those described in a previous
GWAS analyses and detailed information for each cohort is described elsewhere71.
To avert sample overlap, cohorts from the United Kingdom (1985BBC, ALSPAC-Mothers, EPIC-
Norfolk, ORCADES and Twins UK) were excluded from the GWAS meta-analysis. Association analyses
were performed as described elsewhere71For each individual cohort, a single-marker analysis for the
phenotype of SphE (in diopters) was carried out with linear regression with adjustment for age, sex and
up to the first five principal components. For all non-family-based cohorts, one of each pair of relatives
was removed. In family-based cohorts, mixed model-based tests of association were used to adjust for
within-family relatedness.
The European Prospective Investigation into Cancer (EPIC) Study
The EPIC-EPIC is one of the UK arms of a broad pan-European prospective cohort study designed to
investigate the etiology of major chronic diseases72.  This study was conducted following the principles
of the Declaration of Helsinki and the Research Governance Framework for Health and Social Care.  The
study was approved by the Norfolk Local Research Ethics Committee (05/Q0101/191) and East Norfolk &
Waveney NHS Research Governance Committee (2005EC07L).  All participants gave written, informed
consent. Refractive error was measured in both eyes using a Humphrey Auto-Refractor 500 (Humphrey
Instruments, San Leandro, California, USA). Spherical equivalent was calculated as spherical refractive
error plus half the cylindrical error for each eye.
The EPIC-Norfolk participants were genotyped using the Affymetrix UK Biobank Axiom Array (the same
array as used in UK Biobank); 7,117 contributed to the current study.  SNP exclusion criteria included:
call rate < 95%, abnormal cluster pattern on visual inspection, plate batch effect evident by significant
variation in minor allele frequency, and/or Hardy-Weinberg equilibrium P < 10-7. Sample exclusion
criteria included: DishQC < 0.82 (poor fluorescence signal contrast), sex discordance, sample call rate <
97%, heterozygosity outliers (calculated separately for SNPs with minor allele frequency >1% and <1%),
rare allele count outlier, and impossible identity-by-descent values. Individuals with relatedness
corresponding to third-degree relatives or closer across all genotyped participants were also removed
from further analyses.  Following these steps all participants were of European descent. Data were pre-
phased using SHAPEIT66 version 2 and imputed to the Phase 3 build of the 1000 Genomes project74
(October 2014) using IMPUTE70 version 2.3.2.
The relationship between allele dosage and mean spherical equivalent was analyzed using linear
regression adjusted for age, sex and the first 5 principal components.  Analyses were carried out using
SNPTEST version 2.5.1.
Statistical analyses
We conducted two meta-analyses. For the initial meta-analysis (discovery), we used summary statistic
results from the UK Biobank 1st and 2nd subset, the GERA and 23andMe Studies.
For the final meta-analysis, we used all available information (UK Biobank 1 and 2, the GERA, 23andMe
and CREAM Consortium).
For all meta-analyses we applied a Z-score method, weighted by the effective population sample size, as
implemented in METAL75. No genomic control adjustment was applied during the meta-analysis.
The effective population size was calculated per each locus and as was equal to the total sample size if a
linear regression or linear mixed model were used. For case-control studies the effective population was
calculated as: N. eff = 2/( 1. + 1. )
as recommended before76, where N.eff is the effective sample size, N.cases is the number of cases
considered to have myopia and N.controls is the number of subjects considered not to have myopia.
Following this method, we calculated that for the full-sample analysis of 542,934 subjects, due to the
presence of two case-control cohort, our effective sample sizes was 379,227.
Only SNPs with minor allele frequency of at least 1%, which were available from at least 70% of the
maximum number of participants across all studies and that were not missing in more than one strata
(cohorts), were considered further.
Conditional analyses were conducted using the conditional and joint analysis on summary data (COJO) as
implemented in the GCTA program77 to identify independent effects within associated loci as well as the
calculation of the phenotypic variance explained78 by all polymorphisms associated with the trait after the
conditional analyses. The threshold of significance was set at 5x10-08 and the collinearity threshold was
set at r2=0.9.
Genomic inflation was assessed using the package ‘gap’ in R (https://cran.r-project.org/) and to
distinguish between the effect of polygenicity and those arising from sample stratification or uncontrolled
population admixture, the LD score regression intercepts were calculated using the program LD Score
(https://github.com/bulik/ldsc).
Bivariate genetic correlations between refractive error and other complex traits whose summary
statistics are publicly available were assessed following previously described methodologies79, using the
program LD Score (https://github.com/bulik/ldsc).
To assess the potential value of the loci associated with refractive error to predict myopia, regression-
based models were trained and tested separately in two separate groups. The training set comprises the
European UK Biobank participants for whom the spherical equivalent measurements were available. The
models were tested in the EPIC-Norfolk cohort, which was not part of any of the analyses through which
the genetic associations were identified.
The model in included age, sex, and the major genetic variants associated with refractive error after the
conditional analysis. Three different definitions of myopia were used based on sliding spherical
equivalent thresholds: M1 < -0.75D, M2 < -3.00 D and M3 < -5.00D. These three different definitions of
myopia were chosen to correspond to the generally accepted definitions of “any myopia”, “moderate
myopia” and “high myopia”. For the latter, we opted for the -5.00D, because definitions based on the
more stringent threshold of < -6.00D would have not allowed for a sufficient number of cases in the
testing set. For the purpose of these analyses, a “control” was any subject who did not have myopia,
defined by a mean spherical equivalent > -0.5D.
A Receiver Operating Characteristic (ROC) curve was drawn for each case and the Area Under the Curve
(AUC) was calculated.  R programming language and software environment for statistical computing
(https://cran.r-project.org/) was used for both the logistic regression models (‘glm’) and to evaluate the
performance of the model (‘ROCR’).
Polymorphisms associated at a GWAS level (P<5x10-08) were clustered within an “associated genomic
region”, defined as a contiguous genomic region where GWAS-significant markers were within 1 million
base pairs from each other.  Significant polymorphisms were annotated with the gene inside whose
transcript-coding region they are located, or alternatively, if located between two genes, with the gene
nearest to it. The associated genomic regions were collectively annotated with the gene overlapping, or
nearest the most significantly associated variant within that region.
The known relationships between identified genetic loci and other phenotypic traits were derived from
two datasets: the Online Mendelian Inheritance In Man (OMIM, https://omim.org), which is a
continuously curated catalog of human genes and phenotypic changes their polymorphic forms cause in
humans and the GWAS Catalog80 which is a curated catalog of previous GWAS association of SNPs or genes
with other phenotypic traits.
The R (https://cran.r-project.org) package MendelianRandomization v3.4.4 was used for Mendelian
randomization analyses.
Disease-relevant tissues and cell types were identified by analyzing gene expression data together with
summary statistics from the meta-analysis of refractive error in all five cohorts, as described elsewhere81.
Expression data was obtained from the following sources: 1) the GTEx release v7
(https://gtexportal.org/home/datasets) 2) Fetal and adult corneal, trabecular meshwork and ciliary body
RNA sequencing data previously described 82 and 3) data from the subset of subjects with presumed
healthy adult retinas (AMD=1) from datasets described elsewhere83.
As the transcription data were heterogeneous and in different units, expression levels for all tissues were
rank-transformed. Hierarchical clustering was used to help visualize similarities and differences of
patterns of transcript expression across different tissues (‘hclust’ package in R).
SMR (Summary data–based Mendelian randomization) uses GWAS variants as instrumental variables and
gene expression levels or methylation levels as mediating traits, in order to test whether the causal effect
of a specific variant on the phenotype-of-interest acts via a specific gene84. The SMR tests were performed
used three different: the summary statistics of eQTL associations in the untransformed peripheral blood
samples of 5,311 subjects85, as well as eQTL effects and cis- methylation analysis (cis-mQTL), both in brain
tissues86.
The Gene-Set Enrichment Analysis (GSEA) was implemented in the MAGENTA software87. We used the
versions from September 2017.
Results of three statistical tests for natural selection were imported from the 1000 Genomes Selection
Browser88.
Reporting summary
Further information on research design is available in the Nature Research Reporting Summary linked to
this article.
Data availability
Summary statistics from the cohorts participating in the meta-analysis can be downloaded from
ftp://twinr-ftp.kcl.ac.uk/Refractive_Error_MetaAnalysis_2020/ and public repositories such as the
GWAS Catalogue (https://www.ebi.ac.uk/gwas/downloads/summary-statistics). These freely
downloadable summary statistics are calculated using all cohorts described in this manuscript, except
for the 23andMe participants. This is due to a non-negotiable clause in the 23andMe data transfer
agreement, intended to protect the privacy of the 23andMe research participants.
To fully recreate our meta-analytic results, all bona fide researchers can obtain the 23andMe summary
statistics by emailing 23andMe (dataset-request@23andme.com) and subsequently meta-analyzing
them along the freely accessible summary statistics for all the other cohorts.
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Supplementary Figure 1. Principal component plots of the subjects in each of the participating cohorts.
A. UK Biobank
B. GERA
C. 23andMe
Supplementary Figure 2. Correlation of effect sizes between the discovery cohort meta-analysis (UK
Biobank analysis on spherical equivalent + GERA, spherical equivalent + 23andMe, self-reported myopia
cases and controls + UK Biobank inferred myopia cases and controls) and those from the CREAM
Consortium participants, used as replication. The z-scores for the discovery are on the y-axis and those
from the CREAM cohort in the x-axis.
Supplementary Figure 3. Distribution of the base-pair length (red) of the 449 regions associated in the
meta-analysis of all available cohorts (Supplementary Table 3), alongside the distribution of number of
SNPs (blue) for each region. Numbers in each of the axes in the figure are differentially colored to match
the density curve they correspond to: red for the length of the region and blue for the number of SNPs.
Supplementary Figure 4. Expression of genes located in the associated loci (Supplementary Table 3) along the x-axis, across several human body
tissues (y-axis). The colors represent the centile ranking of the expression level of the gene in the tissue of interest. The hotter colors represent
higher ranking of the gene expression and the colder colors low expression. Both genes and tissues are clustered in accordance with their
pattern similarity. The symbol of all the genes could not be visualized and therefore are removed for the sake of clarity. Eye tissues, whether
fetal or adult, appear to have similar patterns of gene expressions (clustered together at the bottom of the figure). Genes that are highly
expressed in eye tissues fall in three clusters, shown with a black box. These clusters are displayed in more detail in Figure 4A, B and C.
Supplementary Figure 5. Genes from the regions associated with RE (from Supplementary Table 3) that
are particularly expressed in eye tissues, compared to non-ocular tissues. These clusters are those
highlighted in Supplementary Figure 3, but for the sake of clarity they are shown in transposed
orientation compared to the previous figure (here genes in the y-axis and eye tissues in the x-axis), but
same color codes as before. The dendrograms represent the degree of similarity observed for both
tissues and gene expressions. The clusters are given in the order in which they were clustered together,
from left to right: A) genes that are expressed more in other ocular tissues (fetal and adult) but much
less in the adult retina. B) genes that are highly expressed in the retina and other ocular tissues, and C)
genes that are expressed in the retina, but less in the other ocular tissues tested.
A)
B)
C)
Supplementary Figure 6. Results of the LD score regression analysis applied to specifically expressed genes (LDSC-SEG) on multiple tissue for the meta-
analysis results. Each point represents one tissue or cell line (along the x-axis) and the log10 value of the p-value of the correlation between the meta-analysis
results and gene expression. There were 205 tests carried out, one in each tissue and cell line, therefore only tissues with a correlation p-value< 0.00025
(Log_P> 3.6 in this figure), would have been significant after multiple testing. This condition was not fulfilled for any of the available tissues.
Supplementary Figure 7. Mendelian randomization results on causality of IOP over refractive error.
Single points in the graph represent coordinates determined by the effect of each specific SNP over IOP
(x-axis, mmHg) and spherical equivalent (y-axis, Diopter units). The lines represent the regression lines
from each model, as specified in the figure legend. In some cases, these lines may not visible because
they overlap (please refer to the values underneath the figure)
Method Estimate SE 95% CI P-value
Simple median -0.049 0.02 -0.088 -0.009 0.016
Weighted median -0.049 0.02 -0.088 -0.009 0.017
IVW -0.047 0.014 -0.073 -0.02 0.001
MR-Egger -0.087 0.038 -0.161 -0.013 0.022
(intercept) 0.005 0.004 -0.004 0.014 0.256
Supplementary Figure 8. Venn’s Diagram of the number of SNPs considered in each of the stages of this
study. The different circles represent various stages, inclusion in the meta-analysis (blue), identification
of significant loci (green), conditional analysis results identifying independent effects (red) and the total
number of SNPs available for inclusion in prediction and heritability estimation in the independent (i.e.
not part of the original meta-analysis) EPIC-Norfolk cohort (orange).
Supplementary Figure 9. Prediction for the total number of SNPs and phenotypic variance explained as
a function of GWAS sample size in future studies, based on the distribution of effects observed in the
current meta-analysis. The plot lines show the predicted relationship between the number of loci
associated with refractive error (left vertical axis, blue line) and the variance they help explain (red line,
right vertical axis), as a function of the sample size (x-axis) used in future GWAS or meta-analyses. These
projections are consistent with the observed results, where an effective sample of 379,227 identified
904 independent signals after a conditional analysis, explaining 12-16% of refractive error variability.
Supplementary Figure 10. The distribution of various natural selection test scores for SNPs associated
with refractive error. The values on the x-axis represent the ranking in terms of natural selection
observed and the y-axis the density of that rank. The different tests show are iHS, XP-EHH (CEU vs YRI),
XP-EHH average score, XP-EHH maximum score and Tajima scores (black, green, red, blue and yellow
respectively)






























